Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
4
×
deals
4
×
life sciences
national blog main
startups
vc
4
×
biotech
boston
national top stories
new york blog main
san francisco blog main
new york top stories
san diego blog main
san francisco top stories
seattle blog main
software
venture capital
acetylon pharmaceuticals
amazon
ambys medicines
american well
apple
arrowmark partners
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
boston children's hospital
boston university
cell therapy
circulation
clinical trials
congenital hyperinsulinism
constellation pharmaceuticals
dacogen
decitabine
delivery services
dexcom
diabetes
What
startup
4
×
biotech
developing
make
medical
medicines
new
acquisition
aiming
aims
amazon’s
ambys
approach
based
beta
big
bionics
blood
called
ceo
circulation
closed
control
deadly
deal
debuted
debuts
device
diabetes
diseases
driven
drugs
efficient
emergency
epigenetic
epigenetics
field
flagship’s
formed
future
Language
unset
Current search:
vc
×
deals
×
photo
×
startup
×
" boston top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?